Acta Chim Slov. 2020 Mar;67(1):159-166.
A new mononuclear cobalt(III) complex, [Co(HL1)2]Cl (1), derived from the reduced Schiff base 2,2'-((ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol (H2L1), and a new dinuclear cobalt(III) complex, [Co2(L2)2]∆2H2O (2), derived from the reduced Schiff base 6,6'-(2-hydroxypropane-1,3-diyl)bis(azanediyl)bis(methylene)bis(2-bromo-4-chlorophenol) (H2L2), were synthesized and characterized by infrared and electronic spectroscopy, and single crystal X-ray diffraction techniques. The ligands were synthesized first, and then bound to the Co(III) centre. Compound 1 contains a mononuclear [Co(HL1)2]+ cation and a chloride anion. The cationic moiety possesses crystallographic inversion center symmetry. Compound 2 contains a dinuclear [Co2(L2)2] molecule and two water hydrate molecules. The Co atoms in the complexes are in octahedral coordination. Both complexes showed potential antimicrobial activity.
一种新型单核钴(III)配合物，[Co(HL1)2]Cl（1），由还原的希夫碱 2,2'-((乙烷-1,2-二基双(氮杂二基))双亚甲基))二酚（H2L1）和一种新型双核钴(III)配合物，[Co2(L2)2]∆2H2O（2），由还原的希夫碱 6,6'-(2-羟基丙烷-1,3-二基)双(氮杂二基)双亚甲基)双(2-溴-4-氯苯酚)(H2L2)合成，并通过红外光谱和电子光谱以及单晶 X 射线衍射技术进行了表征。配体首先合成，然后与 Co(III)中心结合。化合物 1 包含单核[Co(HL1)2]+阳离子和氯离子。阳离子部分具有晶体学反演中心对称。化合物 2 包含一个双核[Co2(L2)2]分子和两个水合水分子。配合物中的 Co 原子采用八面体配位。两种配合物均表现出潜在的抗菌活性。
